Galderma Group AG (GALD.SW) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Switzerland, listed on Swiss. Market cap 38.31B CHF. 52-week range 134.70 to 188.25 CHF. Trailing P/E 56.7. Data as of 2026-10-09.
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in ...